Related Experiment Video
Updated: Feb 12, 2026
06:22
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
1.5K
[Peripartum cardiomyopathy].
Jihad Drissi1, Zakaria Idri1, Jaouad Kouach1
1Service de Gynécologie-Obstétrique, Hôpital Militaire d'Instruction Mohammed V, Rabat, Maroc.
The Pan African Medical Journal
|April 11, 2018
Summary
Peripartum cardiomyopathy (PP-CMP) is a rare heart condition affecting pregnant women, causing heart failure. Early recognition by obstetricians is crucial for timely management of this unpredictable condition.
Area of Science:
- Cardiology
- Obstetrics
- Maternal Health
Background:
- Peripartum cardiomyopathy (PP-CMP), also known as Meadows' syndrome, is a rare form of dilated cardiomyopathy.
- It is defined by heart failure with a left ventricle ejection fraction <45%, occurring during or after pregnancy.
- The exact pathophysiological mechanisms remain poorly understood.
Observation:
- This case report details a 29-year-old primigravida at 32 weeks gestation presenting with acute congestive heart failure.
- The patient was diagnosed with peripartum cardiomyopathy.
- Clinical presentation includes sudden onset of symptoms, unpredictable course, and potential for refractory cardiogenic shock.
Findings:
- PP-CMP necessitates management within a Cardiovascular Unit due to its severity.
- While no specific treatment exists beyond standard heart failure protocols, prompt diagnosis is key.
- The case highlights the importance of considering PP-CMP in pregnant patients with heart failure symptoms.
Implications:
- Obstetricians must be aware of PP-CMP's potential presentation, despite its rarity.
- Timely diagnosis and management can improve outcomes for affected mothers.
- Further research into PP-CMP's etiology and treatment is warranted.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
589
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
589
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
526
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
526
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
587
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
587
01:29Cardiomyopathy V: Interprofessional Care
470
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
470
01:25Cardiomyopathy I: Introduction and Classification
619
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
619
01:29Cardiomyopathy VI: Nursing Management
365
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
365